Treatment for Early-Stage Cervical Cancer
At a Glance
For early-stage cervical cancer, surgery is tailored to tumor size, depth of growth, lymph node risk, and fertility goals. Options may include conization, simple hysterectomy, or radical hysterectomy; open surgery is generally preferred for radical procedures.
When cervical cancer is caught early (Stages IA to IB2), surgery is often the primary treatment. Today, doctors use a tailored approach, choosing the least invasive surgery that is safe based on your specific tumor’s size, how deep it has grown, and your future family goals [1][2].
Defining Early-Stage Surgery
“Early-stage” generally refers to cancer that is confined to the cervix and has not spread to distant sites. The goal of surgery is to remove the cancer while preserving as much healthy tissue and function as possible [3].
- Conization (Cone Biopsy): A small, cone-shaped piece of tissue is removed from the cervix. For highly selected cases—such as microscopic stage IA1 disease with clear margins and no LVSI—this may be the only treatment needed [4]. However, deeper invasion or unfavorable margins can require repeat excision or hysterectomy.
- Simple Hysterectomy: The uterus and cervix are removed, but the surrounding tissue (parametria) and the top of the vagina are left intact [5].
- Radical Hysterectomy: A more extensive surgery where the uterus, cervix, parametria, and the upper part of the vagina are removed. This is often recommended for larger tumors or those that have grown deeper into the cervical tissue [6].
Choosing the Surgical Path: Key Trials
Two major clinical trials have recently changed the standard of care for early-stage cervical cancer surgery, helping doctors decide which approach is safest.
The LACC Trial: Open vs. Minimally Invasive
For many years, radical hysterectomies were often performed using “keyhole” (minimally invasive) or robotic surgery. However, the LACC trial found that selected patients who had open abdominal surgery had better outcomes compared to those who had minimally invasive surgery [7][6].
- The Result: Open surgery is now the recommended standard for radical hysterectomy because it provides a 96.5% disease-free survival rate at 4.5 years compared to 86% for minimally invasive methods [7][8]. Minimally invasive surgery remains a patient-specific discussion for selected situations.
The SHAPE Trial: Simple vs. Radical
For carefully selected patients with “low-risk” tumors (those 2 cm or smaller with limited growth into the cervix), the SHAPE trial investigated if a simple hysterectomy was as safe as a radical one [5][2].
- The Result: Simple hysterectomy was found to be noninferior to radical hysterectomy for preventing pelvic recurrence for these low-risk patients [5].
- The Benefit: Patients had significantly fewer side effects, such as bladder problems (urinary incontinence or retention), and reported a better quality of life [5][9].
Checking the Lymph Nodes
Depending on tumor size, depth, and LVSI, your surgeon will likely check the lymph nodes in your pelvis to see if the cancer has spread.
- Sentinel Lymph Node Biopsy: This is a newer, less invasive method where only the first one or two nodes “downstream” from the tumor are removed and tested. If these are clear, a full dissection may be avoided [10][11].
- Full Pelvic Lymphadenectomy: If sentinel nodes cannot be identified on one or both sides, or if the risk of spread is higher, a side-specific or all the lymph nodes on that side of the pelvis may be removed. This provides more information but carries a higher risk of lymphedema (swelling in the legs) [11].
Crucial Note on Postoperative Pathology: Surgery may not be the final step. Positive pelvic nodes, parametrial involvement, involved margins, or other high-risk findings found after surgery may lead to adjuvant radiation or chemoradiation, with major implications for fertility and toxicity.
Preserving Fertility
If you wish to have children in the future, several options may be available depending on your tumor’s size, depth, LVSI, histology, and margins [3].
- Trachelectomy: Only the cervix is removed, leaving the uterus in place so you can still carry a pregnancy. This can be “simple” or “radical” depending on the tumor [12][13].
- Ovarian Transposition: During surgery, the ovaries are moved higher up in the abdomen, out of the way of potential radiation fields, to protect them from damage. This reduces radiation exposure but does not guarantee preserved ovarian function [14][15].
- Egg/Embryo Freezing: Before starting treatment, you may choose to work with a fertility specialist to freeze eggs or embryos for future use. This preserves gametes, but carrying a pregnancy may require a gestational carrier if the uterus is removed [14].
While fertility-preserving surgeries are successful for many, they do carry a higher risk of preterm birth, so close monitoring by a high-risk pregnancy specialist is usually required later [16].
Common questions in this guide
What surgery is used for early-stage cervical cancer?
Can a simple hysterectomy be as effective as a radical hysterectomy?
Is open surgery preferred for a radical hysterectomy?
Can I preserve my fertility after an early-stage cervical cancer diagnosis?
Will my lymph nodes be removed during cervical cancer surgery?
What happens if cancer is found in the lymph nodes or surgical margins after surgery?
Get notified when new evidence is published on cervical cancer.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
De-escalation in definitive surgical management for cervical cancer.
Viveros-Carreño D, Agustí N, Mora-Soto N, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2025; 102711 doi:10.1016/j.ijgc.2025.102711.
PMID: 41775568 - 2
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Surgical Therapy for Patients with Stage IA2-IIB1 Cervical Cancer.
Fehm T, Beckmann MW, Mahner S, et al.
Geburtshilfe und Frauenheilkunde 2023; (83(10)):1199-1204 doi:10.1055/a-2160-3279.
PMID: 37808259 - 3
ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.
Schmeler KM, Pareja R, Lopez Blanco A, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2021; (31(10)):1317-1325 doi:10.1136/ijgc-2021-002921.
PMID: 34493587 - 4
Initial evaluation of cervical cancer: A literature review of staging conization for accurate risk stratification and guidance of primary treatment in early-stage disease - A review from the French cervical cancer guidelines group.
Chlala W, Favier A, Carcopino X, et al.
Journal of gynecology obstetrics and human reproduction 2026; (55(9)):103274 doi:10.1016/j.jogoh.2026.103274.
PMID: 42710711 - 5
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.
Plante M, Kwon JS, Ferguson S, et al.
The New England journal of medicine 2024; (390(9)):819-829 doi:10.1056/NEJMoa2308900.
PMID: 38416430 - 6
Current Updates on Surgical Management of Patients with Early-Stage Cervical Cancer.
Santía MC, Meschini T, Hsu HC, et al.
Cancers 2025; (17(13)) doi:10.3390/cancers17132259.
PMID: 40647557 - 7
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.
Ramirez PT, Frumovitz M, Pareja R, et al.
The New England journal of medicine 2018; (379(20)):1895-1904 doi:10.1056/NEJMoa1806395.
PMID: 30380365 - 8
Challenges and Controversies in the Surgical Treatment of Cervical Cancer: Open Radical Hysterectomy versus Minimally Invasive Radical Hysterectomy.
Röseler J, Wolff R, Bauerschlag DO, et al.
Journal of clinical medicine 2021; (10(17)) doi:10.3390/jcm10173761.
PMID: 34501212 - 9
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.
Kwon JS, McTaggart-Cowan H, Ferguson SE, et al.
Journal of gynecologic oncology 2024; (35(6)):e117 doi:10.3802/jgo.2024.35.e117.
PMID: 39453395 - 10
Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trial.
Cibula D, Marnitz S, Jarkovský J, et al.
Nature cancer 2025; (6(9)):1585-1594 doi:10.1038/s43018-025-01016-y.
PMID: 40615729 - 11
Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.
Tu H, Huang H, Li Y, et al.
The New England journal of medicine 2025; (393(15)):1463-1474 doi:10.1056/NEJMoa2506267.
PMID: 41092328 - 12
Simple vaginal trachelectomy in women with early-stage low-risk cervical cancer who wish to preserve fertility: the new standard of care?
Plante M, Renaud MC, Sebastianelli A, Gregoire J
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(7)):981-986 doi:10.1136/ijgc-2020-001432.
PMID: 32499393 - 13
Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience.
Danisch M, Kranawetter M, Bartl T, et al.
Journal of personalized medicine 2024; (14(6)) doi:10.3390/jpm14060611.
PMID: 38929833 - 14
Fertility Preservation in Cervical Cancer-Treatment Strategies and Indications.
Salman L, Covens A
Current oncology (Toronto, Ont.) 2024; (31(1)):296-306 doi:10.3390/curroncol31010019.
PMID: 38248104 - 15
Cervical Cancer Treatment and Fertility: What We Know and What We Do.
Habib N, Idoubba S, Futcher F, et al.
Cancers 2025; (17(18)) doi:10.3390/cancers17183057.
PMID: 41008899 - 16
Fertility-Sparing Trachelectomy With Sentinel Node Mapping in Early-Stage Cervical Cancer: Oncological Safety and Obstetric Outcomes From a Single-Institution Study.
Togami S, Furuzono N, Kobayashi Y, et al.
The journal of obstetrics and gynaecology research 2025; (51(10)):e70091 doi:10.1111/jog.70091.
PMID: 41054288
This page provides general information about surgery and fertility preservation for early-stage cervical cancer and is not medical advice. Discuss your tumor, lymph node evaluation, and fertility goals with a gynecologic oncologist and, when appropriate, a fertility specialist.